# COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined

> **NCT01361789** · PHASE4 · COMPLETED · sponsor: **Asker & Baerum Hospital** · enrollment: 93 (actual)

## Conditions studied

- Rupture of Anterior Cruciate Ligament

## Interventions

- **DRUG:** parecoxib, valdecoxib, etoricoxib
- **DRUG:** Dexamethasone
- **DRUG:** parecoxib, valdecoxib, parecoxib and dexamethasone

## Key facts

- **NCT ID:** NCT01361789
- **Lead sponsor:** Asker & Baerum Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2011-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361789, "COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01361789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*